Suppr超能文献

鉴别原发性脑肿瘤复发与放射性损伤:一种应用磁敏感加权成像引导表观弥散系数分析策略的初步研究。

Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy.

机构信息

Centre for Magnetic Resonance, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, Australia.

出版信息

AJNR Am J Neuroradiol. 2010 Jun;31(6):1049-54. doi: 10.3174/ajnr.A2011. Epub 2010 Jan 28.

Abstract

BACKGROUND AND PURPOSE

The accurate delineation of tumor recurrence presents a significant problem in neuro-oncology. Our aim was to improve the identification of brain tumor recurrence from chemoradiation injury by using CE-SWI, a technique that provides improved visualization of the heterogeneous patterns of brain tumor pathology, to guide the analysis of ADC measures within the peritumoral territory.

MATERIALS AND METHODS

Seventeen patients who were being treated for high-grade glial neoplasms took part in the study. All patients presented with new enhancing lesions on follow-up CE-T1. Recurrence or chemoradiation injury was confirmed from either histologic analysis or extensive clinical follow-up. Regions of enhancement on registered CE-SWI and CE-T1 images were extracted in a semiautomated fashion and transferred to co-registered ADC maps. Significant differences in ADC measures defined within the enhancement volumes on serial MR images were analyzed by using a nonparametric Kolmogorov-Smirnov approach and correlated with clinical follow-up diagnoses.

RESULTS

Analysis of the serial data revealed that patients with a diagnosis of tumor recurrence had significantly reduced ADC measures within the enhancement volume delineated on CE-SWI. In contrast, patients with SD had significantly elevated ADC within the CE-SWI enhancement volume.

CONCLUSIONS

The findings of an increase in enhancement volume delineated on serial CE-SWI maps, along with a concomitant reduction in ADC within this volume for patients with recurrent tumor, provide support for such an approach to be used to assist in follow-up patient management strategies.

摘要

背景与目的

在神经肿瘤学中,准确勾画肿瘤复发是一个重大难题。我们旨在通过使用 CE-SWI 来提高对脑肿瘤复发的识别能力,该技术可改善脑肿瘤病理的异质性模式的可视化,以指导对肿瘤周围区域 ADC 测量值的分析,从而解决这一问题。CE-SWI 是一种对比增强磁共振扩散加权成像技术。

材料与方法

17 名正在接受高级别神经胶质瘤治疗的患者参与了本研究。所有患者在随访 CE-T1 时均出现新的增强性病变。通过组织学分析或广泛的临床随访,确认了复发或放化疗损伤。以半自动方式提取注册的 CE-SWI 和 CE-T1 图像上的增强区域,并将其转移到配准的 ADC 图上。使用非参数 Kolmogorov-Smirnov 方法分析在连续 MR 图像上定义的增强体积内 ADC 测量值的显著差异,并与临床随访诊断相关联。

结果

对系列数据的分析表明,诊断为肿瘤复发的患者在 CE-SWI 勾画的增强体积内的 ADC 值明显降低。相比之下,SD 患者在 CE-SWI 增强体积内的 ADC 值明显升高。

结论

对于复发肿瘤患者,CE-SWI 序列图上增强体积的增加以及该体积内 ADC 值的相应降低,为这种方法在协助随访患者管理策略中的应用提供了支持。

相似文献

4
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):151-8. doi: 10.1016/j.ijrobp.2006.12.001. Epub 2007 Feb 7.

引用本文的文献

1
An update on susceptibility-weighted imaging in brain gliomas.
Eur Radiol. 2024 Oct;34(10):6763-6775. doi: 10.1007/s00330-024-10703-w. Epub 2024 Apr 6.
4
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
Clin Neuroradiol. 2018 Sep;28(3):401-411. doi: 10.1007/s00062-017-0584-x. Epub 2017 May 2.
6
Imaging of oligodendroglioma.
Br J Radiol. 2016;89(1060):20150857. doi: 10.1259/bjr.20150857. Epub 2016 Feb 5.
7
Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma.
Quant Imaging Med Surg. 2015 Dec;5(6):835-45. doi: 10.3978/j.issn.2223-4292.2015.12.05.
8
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
J Nucl Med. 2015 Oct;56(10):1554-61. doi: 10.2967/jnumed.113.131516. Epub 2015 Aug 20.
10
Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma.
Semin Radiat Oncol. 2014 Oct;24(4):248-58. doi: 10.1016/j.semradonc.2014.06.008. Epub 2014 Jul 26.

本文引用的文献

2
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.
AJNR Am J Neuroradiol. 2009 Feb;30(2):232-52. doi: 10.3174/ajnr.A1461. Epub 2009 Jan 8.
3
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Lancet Oncol. 2008 May;9(5):453-61. doi: 10.1016/S1470-2045(08)70125-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验